Advertisement
U.S. Markets closed

Taiyen Biotech Co., Ltd. (1737.TW)

Taiwan - Taiwan Delayed Price. Currency in TWD
32.45+0.10 (+0.31%)
At close: 01:30PM CST
Currency in TWD

Valuation Measures4

Market Cap (intraday) 6.49B
Enterprise Value 5.08B
Trailing P/E 21.93
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.02
Price/Book (mrq)0.99
Enterprise Value/Revenue 1.58
Enterprise Value/EBITDA 9.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.27
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 336.35
52 Week Low 332.35
50-Day Moving Average 334.27
200-Day Moving Average 334.10

Share Statistics

Avg Vol (3 month) 3446.62k
Avg Vol (10 day) 3304.86k
Shares Outstanding 5200M
Implied Shares Outstanding 6N/A
Float 8108.05M
% Held by Insiders 149.89%
% Held by Institutions 15.89%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.2
Forward Annual Dividend Yield 43.61%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 44.58
Payout Ratio 481.08%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 20, 2024
Last Split Factor 20:1
Last Split Date 3Dec 16, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 10.85%
Operating Margin (ttm)12.65%

Management Effectiveness

Return on Assets (ttm)2.71%
Return on Equity (ttm)4.47%

Income Statement

Revenue (ttm)3.3B
Revenue Per Share (ttm)16.51
Quarterly Revenue Growth (yoy)-6.40%
Gross Profit (ttm)N/A
EBITDA 554.13M
Net Income Avi to Common (ttm)358.38M
Diluted EPS (ttm)1.48
Quarterly Earnings Growth (yoy)166.20%

Balance Sheet

Total Cash (mrq)1.93B
Total Cash Per Share (mrq)9.65
Total Debt (mrq)247.05M
Total Debt/Equity (mrq)3.81
Current Ratio (mrq)2.44
Book Value Per Share (mrq)32.46

Cash Flow Statement

Operating Cash Flow (ttm)482.38M
Levered Free Cash Flow (ttm)137.07M